Biogen (BIIB) PT Raised to $325 at Mizuho Securities
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $217.89 +1.65%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Mizuho Securities analyst Salim Syed raised the price target on Biogen (NASDAQ: BIIB) to $325.00 (from $270.00) while maintaining a Buy rating.
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Intchains Group Ltd (ICG) PT Lowered to $2 at Benchmark Following 1H Results
- Sinclair Broadcasting (SBGI) PT Raised to $15 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
